September 17, 2013
The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) Second Committee on Drugs, an advisory panel to the health minister, recommended approval on September 13 for two new molecular entities, Janssen Pharmaceutical K.K.’s hepatitis C treatment simeprevir sodium and CSL Behring...read more